LifeQ

Market position

LifeQ describes itself as a global leader in biometric intelligence and wearable technology and states that the majority of the world's smartwatch providers use its algorithms, and that its solutions have been validated as 77% more accurate than competitors; these are company claims. It is positioned across consumer wellness, wearable enablement, insurance and clinical/telemedicine segments, and has been covered by South African and US technology and business media as a health-tech venture.

Stated points of differentiation include validated, clinically oriented accuracy in consumer wearable form factors, breadth of output (150+ biomarkers spanning sleep, cardiac, respiratory, activity and mental health), non-invasive disease screening for conditions such as cardiovascular disease, respiratory disorders and sleep apnea, power-efficient on-device algorithms, the proprietary BioAge biological-age metric, and a science base in computational systems biology and AI.

Technology

The platform combines computational systems biology with cloud-based bio-algorithms applied to wearable sensor signals, notably photoplethysmography, to produce more than 150 physiological biomarkers, non-invasive disease screening and personalised lifestyle recommendations. Algorithms run on-device for smartwatch partners and connect to LifeQ's cloud for advanced biometrics. The company states its algorithms are scientifically and clinically validated and emphasises power efficiency ("more data, less charging") and medical-grade accuracy in consumer form factors. A company study published on bioRxiv in April 2023 addressed the measurement of biological aging using wearables.

Go-to-market

The company goes to market largely through partnerships and enablement: silicon partners (Texas Instruments, Analog Devices, Qualcomm, Maxim Integrated, Pixart, Goodix, Osram, B-Secur), ODMs (Compal, Longcheer, Thunder Soft, Thundercomm, Laisitech, 70mai), platform partners (Google, AWS) and wearable brand customers (Suunto, Montblanc, Xiaomi, Samsung, CE Brands, Fossil Group, TAG Heuer, Louis Vuitton, Rockley, CardieX, 1Life, MMI Holdings). Sector solutions are sold into insurance, telemedicine, corporate health and senior care, complemented by direct consumer sign-ups for LifeQ Health.

Wearable device makers and semiconductor/ODM partners seeking embedded biometric algorithms; insurers seeking continuous health data on insured populations; clinicians, telemedicine providers, researchers and corporate wellness programmes; and individual consumers and families, including senior-care use cases.

Geography

Headquarters in Alpharetta, Georgia, United States, with additional offices in Stellenbosch, South Africa, and in the Netherlands (address listed under Utrecht/Amsterdam). Customers and partners are spread across the United States, Europe, the United Kingdom, China, South Korea, Canada and South Africa, and the investor base is described as spanning five continents.

History

Company-published press listings trace activity from at least 2016, with a concentration of coverage in 2021 around a $47 million investment round, a Nedbank investment, COVID-19 screening applications with 1Life and Samsung South Africa, and a wearables partnership with CONNEQT. In June 2021 the CEO was reported as eyeing a Series B raise the following year. In 2022 and 2023 the company expanded its solution set, announcing the BioAge metric (April 2023), a 24-hour clinical sleep solution (May 2023) and publishing wearable biological-aging research on bioRxiv (April 2023). In November 2023 AAIC Investment announced a strategic investment in LifeQ alongside a partnership to improve health care in Africa. A trade publication reported in October 2024 that the company had raised $50 million.

Risks & controversies

Several prominent claims — global leadership in biometric intelligence, use by the majority of the world's smartwatch providers, and being 77% more accurate than competitors — are company self-assertions on its own website rather than independently verified figures. Reported funding figures differ across sources: a company-listed 2021 item cites a $47 million investment while a 2024 trade article reports a $50 million raise and $50 million total funding, without naming investors.